Pharmacoeconomic analysis in new drug development: A pragmatic approach to efficiency studies

Clinical Research and Regulatory Affairs

Volumn 15, Issue 3-4, 1998, Pages 209-223

  Terrés, Carlos Rubio ^a  

^a Ctra De Burgos   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DEVELOPMENT; DRUG MARKETING; ECONOMIC ASPECT; META ANALYSIS; PHARMACOECONOMICS; SIMULATION;

EID: 0031740745     PISSN: 10601333     EISSN: None     Source Type: Journal    
DOI: 10.3109/10601339809109196     Document Type: Article

References (22)

1. Spector R. Evaluation of benefits of therapy. In: Reynold Spector (Ed). The scientific basis of clinical pharmacology. Principles and examples. Boston: Little Brown and Company, 1986: 13-25.
2. Rubio Terrés C. Diseño estadistico de ensayos clínicos. Med Clin (Barc) 1996; 107: 303-309.
3. Fayers PM, Hand DJ. Generalization from phase III clinical trials: survival, quality of life, and health economics. Lancet 1997; 350: 1025-1027.
4. Sacristán JA. Evaluación económica de fármacos en los ensayos clínicos. In: Sacristán JA, Badía X, Rovira J (Eds). Farmaco-economía. Evaluación económica de medicamentos. Madrid: Editores Médicos SA, 1995: 101-117.
5. Schwartz D, Flamant R, Lellouch J. Clinical trials. London: Academic Press, 1980.
6. Vallbé C. Ensayos abiertos en investigación clínica. In: García Alonso F y Bakke OM (Eds). Metodología del ensayo clinico. Barcelona: Fundación Dr Antonio Esteve, 1991: 49-55.
7. Badía X, Sacristán JA. La evaluación económica de medicamentos: efectos en la industria farmacéutica y en la administración sanitaria. Rev San Hig Púb 1995; 69: 17-27.
8. Chi Tsuen M, Vacani P, Drummond MF. Economic analysis with clinical trials. Applied Clin Trials 1995; Octubre: 60-66.
9. Freemantle N, Drummond M. Should clinical trials with concurrent economic analyses be blinded? JAMA 1997; 277: 63-64.
10. Drummond MF, Jefferson TO on behalf of BMJ Economic evaluation working party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. Br Med J 1996; 313: 275-283.
11. Schwartz D, Pejovic M. The explanatory and pragmatic approaches in clinical trials. In: Steichele C, Abshagen U, Koch-Weser J (Eds). Drugs between research and regulations. Proceedings of the 5th International Meeting of Pharmaceutical Physicians. Munich, October 14-17, 1984. New York: Springer-Verlag, 1986: 113-120.
12. Edwards SJL, Lilford RJ, Braunholtz D, Jackson J. Why "underpowered" trials are not necessarily unethical. Lancet 1997; 350: 804-807.
13. Bootman JL, Larson LN, McGhan WF, Townsend RJ. Pharmaco-economic research and clinical trials: concepts and issues. DCIP 1984; 23: 693-697.
14. Sacristán JA, Soto J, Reviriego J, Galende I. Farmacoeconomía: el cálculo de la eficiencia. Med Clin (Barc) 1994; 103: 143-149.
15. Thacker SB. Meta-analysis. A quantitative approach to research integration. JAMA 1988; 259: 1685-1689.
16. Naylor GD. Meta-analysis and the meta-epidemiology of clinical research Br Med J 1997; 315: 617-619.
17. McDonald RC, Copley-Merriman C. Integración de la evaluación de medicamentos dentro de la industria farmacéutica. Ih: Sacristán JA, Badía X, Rovira J (Eds). Farmacoeconomia. Evaluación económica de medicamentos. Madrid: Editores Médicos, SA, 1995: 203-215.
18. Hearst N, Hulley SB. Utilización de datos secundarios. In: Hulley SB, Cummings SR (Eds). Diseno de la investigación clínica. Un enfoque epidemiológico. Barcelona: Ediciones Doyma, 1993: 59-68.
19. Grabowski H. The effect of pharmacoeconomics on Company research and development decisions. PharmacoEconomics 1997; 11: 389-397.
20. Drummond MF. Economic analysis alongside clinical trials. Int J Tech Ass Health Care 1991; 7: 561-573.
21. Kirchner V. Clinical studies to assess the economic impact of new therapies: pragmatic approaches to measuring costs. Anti-cancer drugs 1993; 4 (Supl. 3): 13-20.
22. Argimón JM, Jiménez J. Métodos de investigación aplicados a la atención primaria de salud. Barcelona: Mosby/Doyma Libros, 1995.